AlexanderMdStojadinovicMDMBA MSc FACS(He/Him)

Summary

• Chief Clinical Consultant, BLA-Regulatory
  For >30 years’ experience in clinical practice, drug clinical development, and R&D in innovative drug development, Dr. Stojadinovic is a servant leader with noble purpose – to improve the quality and duration of life for populations of patients suffering from cancer. He's an expert for drug clinical development that designs and executes immune-oncology clinical trials and for building effective and enduring international private-public partnerships based on mutual trust and shared vision to support cooperative multi-center clinical trials aimed at addressing relevant clinical needs. Designs and executes immune-oncology clinical trials. Responsible for Sponsor, study site and clinical trial management.
  Completed wide range of projects involving strategic decisions, due diligence, and joint venture assessments, clinical study evaluation, data audits, development of product support documents, general regulatory support, and litigation support.
  Senior Medical Director in GSK responsible for clinical research activities pertaining to advancing clinical cancer therapy portfolio.
  Leading clinical data generation activities.
  Analyzed, interpreted, presented, published clinical trial data.
  Oversaw all aspects of Phase 1-4 global development programs in variety of therapeutic areas.
  Surgery and oncology expert to educate, address, and resolve clinical inquiries from external providers and internal partners.
  Clinical leadership and industry expertise supporting the development of strategies.
  Clinical research expert for developing Translational Science strategy for early drug development, including the use of genomics, proteomics, biomarker development and licensing strategy.
  Strategic support for product clinical development and FDA interactions.
  Providing strategy development and strategy execution expertise for the delivery of high-quality evidence-based, patient-centered, multi-disciplinary care for patients with advanced cancer.

Dr. Stojadinovic - BLA Regulatory
Chief Clinical Consultant Dr. Stojadinovic, MD, MBA, MSc, FACS For more than 30 years' experience in clinical practice, drug clinical development, and R&D in in